Background: Hepatitis D virus (HDV), a defective RNA virus leads to the most aggressive form of viral hepatitis. HDV is thought to be relatively uncommon in the U.S. and its prevalence and significance in those with HIV is virtually unknown. Furthermore, serologic detection methods may under-represent true prevalence. We sought to assess the prevalence of HDV RNA in a Midwestern cohort of patients with HBV-HIV coinfection and a comparison group with HBV alone.
Methods: We developed and validated a qRT-PCR methodology for detection of HDV RNA. Briefly, viral RNA was extracted using a QIAamp viral RNA mini kit, followed by qRT-PCR in a BioRad CFX96 platform. A 93 BP region was amplified. The assay was validated by sequence analysis of the amplicon products with comparison to published sequences. The initial cohort was then tested and associated clinical data were obtained. Statistical analysis was performed using Statistix 10.0.
Results: 138 subjects (48 HBV-positive/HIV-negative and 90 HBV-positive/HIV-positive) were evaluated. The mean age was 38. 83% were male. 17% were on HBV active therapy. Two subjects were found to be HDV RNA positive, both from the HBV/HIV group. The mean ALT level in the HDV positives was 228 U/L vs. 96 U/L in HDV negative. Both were African-American; one was born in the U.S. and the other in Africa. Cirrhosis was not present in either patient. Neither reported IDU as a risk factor. No samples were positive in the cohort with HBV alone.
Conclusions: Our analysis suggests HDV prevalence in those with HBV/HIV coinfection of 2% (p = 0.2, CI 0-5.3%) as compared to 0% in the HIV-negative cohort. Cirrhosis was not present in either subject found to have HDV coinfection though mean ALT level was higher. Further analysis of larger cohorts appears warranted because presence of HDV RNA was unsuspected in these patients.